Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
11h
Halozyme’s Patent Challenges and New Licensing Platform Lead to Hold Rating
Leerink Partners analyst David Risinger maintained a Hold rating on Halozyme (HALO – Research Report) yesterday and set a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Grateful Dead bassist dies
Sentenced for Jan. 6 role
Arlington incident report
Apology for past US policy
Dismissal of charge upheld
DNA tests identify skull
Voter punches poll worker
NASA astronaut hospitalized
Jeffries pleads not guilty
Israel strikes back at Iran
World's most valuable firm
Joe Rogan hosts Trump
Delta sues CrowdStrike
CO ballots to be reexamined
Seeks MI ballot exit
SC teen voting glitch
MS late ballots count ruling
Murder-for-hire plot arrest
Won't endorse candidates
E. coli infections rise to 75
Recalls chicken products
Approves Iterum's treatment
VA voter roll purge blocked
Announces layoffs, jet sales
Madigan corruption trial
Gaza peace talks to resume?
'Spider-Man 4' set for '26
Favre to campaign w/ Trump
Hit w/ discrimination claims
Strike kills 3 journalists
New student loan relief plan
Louisiana forces relocation
Related topics
Halozyme
Johnson & Johnson
Feedback